Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Arquivos brasileiros de oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000200013 |
Resumo: | A 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex ®) implantation for posterior uveitis in the left eye. Varicella zoster virus (VZV) DNA was detected in the anterior chamber and vitreous samples on polymerase chain reaction (PCR) analysis. Retinal detachment occurred despite systemic and intravitreal antiviral therapy. Favorable structural and functional outcomes were achieved after retinal surgery with silicone oil. To the authors’ knowledge, this is the first reported case of acute retinal necrosis following placement of an Ozurdex® implant. Physicians practicing Ozurdex® implantations should be aware of this unusual but devastating complication. Extra caution and frequent follow-up are required in all immunocompromised patients receiving Ozurdex® implantation. |
id |
CBO-2_21ad63a28206714ab0c1c49b7ea07d80 |
---|---|
oai_identifier_str |
oai:scielo:S0004-27492015000200013 |
network_acronym_str |
CBO-2 |
network_name_str |
Arquivos brasileiros de oftalmologia (Online) |
repository_id_str |
|
spelling |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implantRetinal necrosis syndrome, acuteImmunosuppressionIntravitreal injections/methodsDexamethasone/administration & dosageCase reportsA 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex ®) implantation for posterior uveitis in the left eye. Varicella zoster virus (VZV) DNA was detected in the anterior chamber and vitreous samples on polymerase chain reaction (PCR) analysis. Retinal detachment occurred despite systemic and intravitreal antiviral therapy. Favorable structural and functional outcomes were achieved after retinal surgery with silicone oil. To the authors’ knowledge, this is the first reported case of acute retinal necrosis following placement of an Ozurdex® implant. Physicians practicing Ozurdex® implantations should be aware of this unusual but devastating complication. Extra caution and frequent follow-up are required in all immunocompromised patients receiving Ozurdex® implantation.Conselho Brasileiro de Oftalmologia2015-04-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000200013Arquivos Brasileiros de Oftalmologia v.78 n.2 2015reponame:Arquivos brasileiros de oftalmologia (Online)instname:Conselho Brasileiro de Oftalmologia (CBO)instacron:CBO10.5935/0004-2749.20150030info:eu-repo/semantics/openAccessKucukevcilioglu,MuratEren,MustafaYolcu,UmitSobaci,Gungoreng2015-04-27T00:00:00Zoai:scielo:S0004-27492015000200013Revistahttp://aboonline.org.br/https://old.scielo.br/oai/scielo-oai.phpaboonline@cbo.com.br||abo@cbo.com.br1678-29250004-2749opendoar:2015-04-27T00:00Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO)false |
dc.title.none.fl_str_mv |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
title |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
spellingShingle |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant Kucukevcilioglu,Murat Retinal necrosis syndrome, acute Immunosuppression Intravitreal injections/methods Dexamethasone/administration & dosage Case reports |
title_short |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
title_full |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
title_fullStr |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
title_full_unstemmed |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
title_sort |
Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant |
author |
Kucukevcilioglu,Murat |
author_facet |
Kucukevcilioglu,Murat Eren,Mustafa Yolcu,Umit Sobaci,Gungor |
author_role |
author |
author2 |
Eren,Mustafa Yolcu,Umit Sobaci,Gungor |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Kucukevcilioglu,Murat Eren,Mustafa Yolcu,Umit Sobaci,Gungor |
dc.subject.por.fl_str_mv |
Retinal necrosis syndrome, acute Immunosuppression Intravitreal injections/methods Dexamethasone/administration & dosage Case reports |
topic |
Retinal necrosis syndrome, acute Immunosuppression Intravitreal injections/methods Dexamethasone/administration & dosage Case reports |
description |
A 52-year-old woman undergoing azathioprine treatment for rheumatoid arthritis developed acute retinal necrosis a month after intravitreal dexamethasone (Ozurdex ®) implantation for posterior uveitis in the left eye. Varicella zoster virus (VZV) DNA was detected in the anterior chamber and vitreous samples on polymerase chain reaction (PCR) analysis. Retinal detachment occurred despite systemic and intravitreal antiviral therapy. Favorable structural and functional outcomes were achieved after retinal surgery with silicone oil. To the authors’ knowledge, this is the first reported case of acute retinal necrosis following placement of an Ozurdex® implant. Physicians practicing Ozurdex® implantations should be aware of this unusual but devastating complication. Extra caution and frequent follow-up are required in all immunocompromised patients receiving Ozurdex® implantation. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000200013 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000200013 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/0004-2749.20150030 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
dc.source.none.fl_str_mv |
Arquivos Brasileiros de Oftalmologia v.78 n.2 2015 reponame:Arquivos brasileiros de oftalmologia (Online) instname:Conselho Brasileiro de Oftalmologia (CBO) instacron:CBO |
instname_str |
Conselho Brasileiro de Oftalmologia (CBO) |
instacron_str |
CBO |
institution |
CBO |
reponame_str |
Arquivos brasileiros de oftalmologia (Online) |
collection |
Arquivos brasileiros de oftalmologia (Online) |
repository.name.fl_str_mv |
Arquivos brasileiros de oftalmologia (Online) - Conselho Brasileiro de Oftalmologia (CBO) |
repository.mail.fl_str_mv |
aboonline@cbo.com.br||abo@cbo.com.br |
_version_ |
1754209028551999488 |